Enanta Pharmaceuticals

ENTA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

Previous year: $1.96M

+57.1%

R&D Expenses

$20.9M

Previous year: $27.7M

-24.6%

G&A Expenses

$9.01M

Previous year: $12.8M

-29.9%

Cash and Equivalents

$37.4M

Previous year: $84.3M

Loading...

Enanta Pharmaceuticals

Unlock previous datapoints

Upgrade

Enanta Pharmaceuticals

Unlock previous datapoints

Upgrade

Enanta Pharmaceuticals Revenue by Segment

Revenue by Segment

Royalty Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$351M

P/E Ratio

-9.76

Sector

N/A

Industry

N/A

52-Week High

$16.8

52-Week Low

$4.25

Interest Expense

$3.08M

R&D Expenses

$20.9M

G&A Expenses

$9.01M

Interest & Investment Income, Net

$2.42M

Income Tax (Expense) Benefit

-$24K

Products

Get in Touch

Resources

Enanta Pharmaceuticals

Enanta Pharmaceuticals

Enanta Pharmaceuticals

Enanta Pharmaceuticals Revenue by Segment

Revenue by Segment

Royalty Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics